Latest filing published 25 May 2022 for Acerus Pharmaceuticals Corporation, €23k.
This profile gathers the share dealings of Samuel Herschkowitz in Acerus Pharmaceuticals Corporation. Between 7 March 2022 and 25 May 2022, the trades on record add up to 3 filings.
On the market, this insider has only ever bought: 2 purchases, €28k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 25 May 2022 with an open-market purchase (€23k) in Acerus Pharmaceuticals Corporation. Most trades are made public on the day they happen. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations